YD Bio Ltd - YDES

Sector: Healthcare · Industry: Biotechnology
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.721M
QoQ value delta ($000)
-$1.691M (-49.56%)
Implied price effect (QoQ)
-37.47%
Shares
Total shares
141,580
QoQ shares delta
-33,928 (-19.33%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (YDES)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
GEODE CAPITAL MANAGEMENT, LLC 711 58,363 0.0%
Cerity Partners LLC 395 32,406 0.0%
Cypress Capital Management LLC (WY) 335 27,540 0.31%
CITADEL ADVISORS LLC 140 11,549 0.0%
UBS Group AG 87 7,192 0.0%
WOLVERINE ASSET MANAGEMENT LLC 30 2,516 0.0%
CITIGROUP INC 20 1,709 0.0%
MORGAN STANLEY 3 299 0.0%
BANK OF AMERICA CORP /DE/ 0 5 0.0%
FMR LLC 0 1 0.0%